LENSAR, Inc. Share Price & Technical Analysis
LNSR · $6.09 (+2.35%)
Healthcare / Medical Devices
$6.09
+2.35%
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies desi…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
15% return in May, 15% avg return in past 3 year May month.
-48% return in 2026, 70% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | -5% | -49% | -17% | 15% | – | – | – | – | – | – | – | -48% |
| 25 | 25% | 20% | 9% | 0% | -4% | -2% | -2% | -4% | 2% | -1% | -17% | 12% | 39% |
| 24 | 3% | 40% | -29% | -11% | 52% | -4% | 14% | -11% | 0% | 27% | 36% | 17% | 132% |
| 23 | 0% | -3% | -19% | 21% | -3% | 40% | -21% | 3% | -9% | -29% | 19% | 40% | 38% |
| 22 | -3% | 0% | 25% | -1% | -7% | -3% | -3% | -16% | -3% | -14% | -31% | -6% | -63% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$69.78M
P/E ratio
—
52W high
$13.74
52W low
$5.06
Volume
44,984
Beta
0.84
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is LENSAR, Inc. share price today?
- LENSAR, Inc. (LNSR) last traded around $6.09 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LNSR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LNSR. Download the app for real-time alerts.
- How can I analyze LENSAR, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.